Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;43(1):539-546.
doi: 10.1080/08897077.2021.1967836. Epub 2021 Sep 14.

Opioid treatment programs, telemedicine and COVID-19: A scoping review

Brian Chan  1   2 , Christina Bougatsos  1 , Kelsey C Priest  3 , Dennis McCarty  1   4 , Sara Grusing  1 , Roger Chou  1
Affiliations

Opioid treatment programs, telemedicine and COVID-19: A scoping review

Brian Chan et al. Subst Abus. 2022.

Abstract

Background: Methadone and buprenorphine are effective medications for opioid use disorder (MOUD) that are highly regulated in the United States. The on-going opioid crisis, and more recently COVID-19, has prompted reconsideration of these restrictions in order to sustain and improve treatment access, with renewed interest in telemedicine. We reviewed the evidence on use of telemedicine interventions and applicability to MOUD policy changes in the post-COVID-19 treatment landscape. Methods: Ovid MEDLINE and the Cochrane Database of Systematic Reviews databases were searched from inception to April 2021 and reference lists were reviewed to identify additional studies. Studies were eligible if they examined telemedicine interventions and reported outcomes (e.g. treatment initiation, retention in care). Randomized trials and controlled observational studies were prioritized; other studies were included when stronger evidence was unavailable. One investigator abstracted key information and a second investigator verified data. We described the results qualitatively. Results: We identified nine studies: three controlled trials (two randomized), and six observational studies. Three studies evaluated patients treated with methadone and six studies with buprenorphine, including one study of pregnant women with OUD. All studies showed telemedicine approaches associated with similar outcomes (treatment retention, positive urine toxicology) compared to treatment as usual. Trials were limited by small samples sizes, lack of reporting harms, and most were conducted prior to the COVID-19 pandemic; observational studies were limited by failure to control for confounding. Conclusions: Limited evidence suggests that telemedicine may enhance access to MOUD with similar effectiveness compared with face-to-face treatment. Few studies have been published since COVID-19, and it is unclear the potential impact of these interventions on the existing racial/ethnic disparities in treatment. The COVID-19 pandemic and need for social distancing led to temporary policy changes for prescribing of MOUD that could inform additional research in this area to support comprehensive policy reforms.

Keywords: COVID-19; Telemedicine; buprenorphine; methadone; opioid use disorder.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scoping Review Search Tree
See this image and copyright information in PMC

References

    1. Substance Abuse and Mental Health Services Administration. Statutes, Regulations, and Guidelines. Accessed August 31, 2020, https://www.samhsa.gov/medication-assisted-treatment/statutes-regulation...
    1. Joudrey PJ, Edelman EJ, Wang EA. Drive times to opioid treatment programs in urban and rural counties in 5 US States. Jama. Oct 1 2019;322(13):1310–1312. doi:10.1001/jama.2019.12562 - DOI - PMC - PubMed
    1. Madras BK. The President’s Commission on Combating Drug Addiction and the Opioid Crisis: Origins and Recommendations. Research Support, N.I.H., Extramural. Clin Pharmacol Ther. 06 2018;103(6):943–945. doi:10.1002/cpt.1050 - DOI - PubMed
    1. Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. DEA and Department of Justice. Federal Register, Vol 74 (64) Monday April 6, 2009. Rules and Regulations. - PubMed
    1. Substance Abuse and Mental Health Services Administration. FAQs: Provision of methadone and buprenorphine for the treatment of opioid use disorder in the COVID-19 emergency. Accessed August 31, 2020, https://www.samhsa.gov/sites/default/files/faqs-for-oud-prescribing-and-...

Publication types